Predictors of Airway Intervention in Angiotensin‐Converting Enzyme Inhibitor–Induced Angioedema
- 17 June 2015
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 153 (4) , 544-550
Abstract
Objectives: Identify factors associated with angiotensin‐converting enzyme inhibitor–induced angioedema (AIIA), including (1) time of presentation, (2) clinical symptoms, and (3) anatomical regions in the head and neck, that may indicate need for airway intervention.Study Design: Case series with chart review.Setting: Three university tertiary care hospitals.Subjects and Methods: Medical records of adult patients presenting to the emergency department (ED) diagnosed with AIIA within a 3‐year period were reviewed. Time at presentation, presenting symptoms, physical examination findings, treatment, length of hospitalization, and outcomes were examined. Univariate analysis was performed.Results: 311 patients were diagnosed with AIIA and evaluated with flexible laryngoscopy by an otolaryngologist. Patients requiring airway intervention most often presented within 4 hours of onset. Dysphagia, dysphonia, drooling, respiratory distress, and globus sensation were associated with airway intervention (χ2 range, 9.1‐47.1). Patients with edema of the face, lower lip, and upper lip were at low risk for airway intervention (odds ratio = 0.4, 0.3, and 0.4, respectively; all P values <.05), while those with involvement of the tongue, soft palate, vallecula, aryepiglottic folds, and true vocal cords were associated with highest risk (odds ratio = 11.1, 12.3, 9.9, 8.5, and 33.5, respectively; all P values <. 001).Conclusion: This is the largest patient series to date of AIIA patients evaluated with flexible laryngoscopy. Physicians should be aware of certain risk factors that will require a higher acuity level of care, including (1) presentation within 4 hours of symptom onset, (2) symptoms such as drooling and respiratory distress, (3) and involvement of the tongue, soft palate, and larynx.Keywords
This publication has 13 references indexed in Scilit:
- A Randomized Trial of Icatibant in ACE-Inhibitor–Induced AngioedemaNew England Journal of Medicine, 2015
- Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin–Angiotensin System InhibitorsThe American Journal of Cardiology, 2012
- Management of angiotensin‐converting enzyme inhibitor–induced angioedemaThe Laryngoscope, 2011
- Site involvement as a predictor of airway intervention in angioedemaThe Laryngoscope, 2011
- Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case SeriesAnnals of Emergency Medicine, 2010
- Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme InhibitorsHypertension, 2008
- Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency departmentAnnals of Allergy, Asthma & Immunology, 2008
- Clinical experience with angiotensin‐converting enzyme inhibitor–induced angioedemaOtolaryngology–Head and Neck Surgery, 2007
- Bradykinin and the pathophysiology of angioedemaInternational Immunopharmacology, 2003
- Increased sensitivity to bradykinin among African AmericansJournal of Allergy and Clinical Immunology, 1996